Evidence map›Paper›PMID 32494563›Full record

ArticleIntractable & rare diseases research2020

Food intolerance/malabsorption may occur in rare diseases.

Wolfgang J Schnedl, Manfred Tillich, Michael Schenk, Dietmar Enko, Harald Mangge

Open access · diamondAbstract read
In one paragraph

Article in Intractable & rare diseases research, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.7field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Wolfgang J SchnedlGeneral Internal Medicine Practice, Dr. Theodor Körnerstrasse 19b, Bruck, Austria.
Manfred TillichDiagnostikum Sued-West, Weblinger Guertel 25, Graz, Austria.
Michael SchenkDas Kinderwunsch Institut Schenk GmbH, Am Sendergrund 11, Dobl, Austria.
Dietmar EnkoClinical Institute of Medical and Chemical Laboratory Diagnosis, Medical University of Graz, Auenbruggerplatz 30, Graz, Austria.
Harald ManggeClinical Institute of Medical and Chemical Laboratory Diagnosis, Medical University of Graz, Auenbruggerplatz 30, Graz, Austria.
Medical University of Graz · ATAnton Bruckner Private University · AT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Sugars including lactose and fructose, or proteins (gluten), or biogenic amines (histamine), and combinations thereof may cause food intolerance/malabsorption. However, in usually asymptomatic patients with rare diseases, who present with functional, non-specific, non-allergic gastrointestinal (GI) complaints the etiologic factors of food intolerance/malabsorption need to be evaluated. We summarize patients with rare diseases, such as primary epiploic appendagitis, beta-thalassemias minor, Gullo syndrome and anomaly of the inferior vena cava, who presented functional, non-specific, non-allergic GI complaints. As conclusion, these GI symptoms in patients with otherwise asymptomatic, rare diseases were due to fructose malabsorption, histamine-, lactose intolerance and

Indexed as

histamineprimary epiploic appendagitis; Gullo syndrome; beta-thalassemia minor; inferior vena cava anomaly; lactose; fructose

Identifiers

PMID32494563
PMCPMC7263995
OpenAlexW3024350404

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.